Showing results (31-40 of 1,764) with videos related to
Sort By:
Pageof 177
JAMA Neurology|January 31, 2022
Amyloid-Related Imaging Abnormalities and β-Amyloid-Targeting Antibodies: A Systematic ReviewMassimo Filippi, Giordano Cecchetti, Edoardo Gioele Spinelli, et al.JAMA Neurology|July 9, 2019
Safety and Efficacy of Edonerpic Maleate for Patients With Mild to Moderate Alzheimer Disease: A Phase 2 Randomized Clinical TrialLon S Schneider, Ronald G Thomas, Suzanne Hendrix, et al.JAMA Neurology|February 28, 2022
Neurologic Prognostication After Cardiac Arrest Using Brain Biomarkers: A Systematic Review and Meta-analysisRyan L Hoiland, Kiran J K Rikhraj, Sharanjit Thiara, et al.JAMA Neurology|May 19, 2015
Imaging Correlates of Memory and Concussion History in Retired National Football League AthletesJeremy F Strain, Kyle B Womack, Nyaz Didehbani, et al.JAMA Neurology|May 19, 2015
Long-term Therapy With Interleukin 6 Receptor Blockade in Highly Active Neuromyelitis Optica Spectrum DisorderMarius Ringelstein, Ilya Ayzenberg, Jens Harmel, et al.JAMA Neurology|August 30, 2021
Risk of Rupture After Intracranial Aneurysm GrowthLaura T van der Kamp, Gabriel J E Rinkel, Dagmar Verbaan, et al.JAMA Neurology|August 23, 2021
Sex-Specific Association of the X Chromosome With Cognitive Change and Tau Pathology in Aging and Alzheimer DiseaseEmily J Davis, Caroline W Solsberg, Charles C White, et al.JAMA Neurology|July 14, 2015
Treatment Outcomes With Rituximab in 100 Patients With Neuromyelitis Optica: Influence of FCGR3A Polymorphisms on the Therapeutic Response to RituximabSu-Hyun Kim, In Hye Jeong, Jae-Won Hyun, et al.JAMA Neurology|July 7, 2015
Longitudinal Cerebrospinal Fluid Biomarker Changes in Preclinical Alzheimer Disease During Middle AgeCourtney L Sutphen, Mateusz S Jasielec, Aarti R Shah, et al.Pageof 177